CAS 57773-63-4
:Triptorelin
Description:
Triptorelin is a synthetic peptide and a gonadotropin-releasing hormone (GnRH) analog, primarily used in the treatment of hormone-sensitive conditions such as prostate cancer, endometriosis, and precocious puberty. It is characterized by its ability to inhibit the secretion of gonadotropins (LH and FSH) from the pituitary gland, leading to a decrease in testosterone and estrogen levels. Triptorelin is typically administered via injection and has a prolonged action compared to natural GnRH due to its structural modifications, which enhance its stability and bioavailability. The substance is known for its efficacy in managing hormone-related disorders, but it may also have side effects, including hot flashes, mood changes, and potential impacts on bone density with long-term use. Its chemical structure includes a sequence of amino acids that mimic the natural hormone, allowing it to bind effectively to GnRH receptors. As a therapeutic agent, Triptorelin is classified under the category of hormonal therapies and is subject to regulation in various medical contexts.
Formula:C66H88N18O15
InChI:InChI=1/C42H59N11O9.C22H25N7O4.C2H4O2/c1-24(2)19-31(37(58)50-30(9-5-16-46-42(44)45)41(62)53-17-6-10-34(53)40(61)48-23-35(43)56)51-39(60)33(21-26-22-47-29-8-4-3-7-28(26)29)52-38(59)32(49-36(57)15-18-54)20-25-11-13-27(55)14-12-25;23-20(31)17(7-12-9-25-15-4-2-1-3-14(12)15)28-22(33)18(8-13-10-24-11-26-13)29-21(32)16-5-6-19(30)27-16;1-2(3)4/h3-4,7-8,11-14,22,24,30-34,47,54-55H,5-6,9-10,15-21,23H2,1-2H3,(H2,43,56)(H,48,61)(H,49,57)(H,50,58)(H,51,60)(H,52,59)(H4,44,45,46);1-4,9-11,16-18,25H,5-8H2,(H2,23,31)(H,24,26)(H,27,30)(H,28,33)(H,29,32);1H3,(H,3,4)/t30-,31-,32-,33+,34-;16-,17-,18-;/m00./s1
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
(D-Trp⁶)-LHRH
CAS:A long-acting GnRH agonist. Pamoate is the bivalent anion of pamoic acid (embonic acid, 4,4·-methylene-bis-(3-hydroxy-2-naphthoic acid)). CAS-number (triptorelin pamoate) 124508-66-3.Formula:C64H82N18O13Purity:99.09%Color and Shape:Light YellowMolecular weight:1311.47(D-Trp⁶)-LHRH
CAS:LHRH agonist used in the treatment of prostate cancer. Triptorelin decreases the secretion of LH and FSH. CAS-number (triptorelin acetate) 140194-24-7.Formula:C64H82N18O13Purity:99.2%Color and Shape:WhitishMolecular weight:1311.47Triptorelin Acetate (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate salt)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C64H82N18O13·C2H4O2Color and Shape:White PowderMolecular weight:1370.652Triptorelin-d4 Trifluoroacetate (Mixture of Isomers)
CAS:Formula:C64H78D4N18O13·C2HF3O2Molecular weight:1315.50 114.02Triptorelin-d7 Ditrifluoroacetate
CAS:Formula:C64H75D7N18O13·2C2HF3O2Molecular weight:1318.52 2*114.02Triptorelin ([DTrp6]-LH-RH)
CAS:<p>Triptorelin is a GnRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo: (1) Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GnRHR-I expression of female rats, especially in late-growing follicles.(2) Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.<br>[1]. Wei S et al. Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice. Immunopharmacol Immunotoxicol. 2016 Jun;38(3):197-204.</p>Formula:C64H82N18O13Color and Shape:PowderMolecular weight:1311.45Triptorelin Acetate
CAS:Formula:C64H82N18O13Purity:95%~99%Color and Shape:White to Off-white PowderMolecular weight:1311.45Triptorelin Trifluoroacetic Acid Salt-d5
CAS:Controlled Product<p>Applications Labelled synthetic peptide agonist analog of LH-RH. Triptoreline is a potent agonist of LH-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Antineoplastic (hormonal). Used in the treatment of endometriosis and infertility.<br>References Sanders, L., et al.: Eur. J. Drug Metab. Pharmacokinet., 15, 95 (1990), Chiba, M., et al.: Biomaterials, 18, 893 (1997), Blanco, D., et al.: Eur. J. Pharm. Biopharm., 45, 285 (1998), Sinha, V., et al.: J. Control. Rel., 90, 261 (2003),<br></p>Formula:C64H77D5N18O13x(C2HF3O2)Color and Shape:NeatMolecular weight:1316.4811402Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-
CAS:Formula:C64H82N18O13Purity:98%Color and Shape:SolidMolecular weight:1311.4487Ref: IN-DA01DQA5
Discontinued product








